Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythema multiforme during GM-CSF therapy

R Stasi1, S Gatti, A Perrotti

  • 1Department of Haematology, University Tor Vergata of Rome, S. Eugenio Hospital, Italy.

Acta Dermato-Venereologica
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung ultrasound for the diagnosis and monitoring of community-acquired pneumonia in children: a prospective observational study.

Frontiers in pediatrics·2026
Same author

Scapular dyskinesis after breast reconstruction surgery for breast cancer: a retrospective clinical analysis on 67 patients.

Musculoskeletal surgery·2025
Same author

Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study).

Clinical colorectal cancer·2024
Same author

To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.

PloS one·2023
Same author

Acute and chronic effects of Titanium dioxide (TiO<sub>2</sub>) PM<sub>1</sub> on honey bee gut microbiota under laboratory conditions.

Scientific reports·2021
Same journal

A Facial Lesion with Cord-like Induration and Ring-like Appearance on MRI: A Quiz.

Acta dermato-venereologica·2026
Same journal

Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study.

Acta dermato-venereologica·2026
Same journal

An 8-year-old Girl with Multiple Whitish Dots on the Hair Shaft: A Quiz.

Acta dermato-venereologica·2026
Same journal

A Congenital Subcutaneous Tumour of the Scalp in a Child: A Quiz.

Acta dermato-venereologica·2026
Same journal

Commentary on: "The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma".

Acta dermato-venereologica·2026
Same journal

Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study.

Acta dermato-venereologica·2026
See all related articles

Granulocyte-macrophage colony-stimulating factor (GM-CSF) may trigger erythema multiforme in susceptible individuals. This reaction is linked to immune system recovery and elevated cytokine levels, suggesting a potential mechanism involving immune dysregulation.

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine used to stimulate white blood cell production.
  • Erythema multiforme is an acute, self-limiting hypersensitivity reaction of the skin and mucous membranes.

Observation:

  • A 52-year-old male patient developed erythema multiforme during treatment with GM-CSF.
  • The eruption coincided with peripheral blood lymphocyte recovery and elevated serum levels of interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), and tumor necrosis factor-alpha.

Findings:

  • The patient's cutaneous eruption presented with clinical and histologic features characteristic of erythema multiforme.
  • Laboratory data indicated a temporal association between GM-CSF therapy, lymphocyte recovery, and the onset of the skin reaction.

Related Experiment Videos

Implications:

  • GM-CSF may induce erythema multiforme in predisposed individuals.
  • The reaction might be mediated by aberrant cytokine secretion or abnormal immune amplification following lymphocyte recovery.
  • This case highlights a potential adverse effect of GM-CSF therapy and warrants further investigation into immune-mediated mechanisms.